Psychiatry and Clinical Psychopharmacology
Case Report

Topiramate in the Adjunctıve Treatment of Tourette Syndrome: A Case Report


Izmir Dr. Behcet Uz Children’s Research and Training Hospital, Department of Child and Adolescent Psychiatry, Izmir - Turkey

Psychiatry and Clinical Psychopharmacology 2016; 26: 426-428
DOI: 10.5455/bcp.20151223092807
Read: 787 Downloads: 449 Published: 21 January 2021

 Tourette Syndrome (TS) is an inherited neuropsychiatric disorder with onset in childhood, characterized by multiple motor tics and at least one vocal tic. In many of the cases, Attention Deficit Hyperactivity Disorder (ADHD) is a frequent comorbid disorder. Many treatment options have been suggested for TS and ADHD comorbidity. In this article, we present a case diagnosed with TS and ADHD whose tics were refractory to many other suggested treatment options for Tic Disorders (TD) and worsened during the use of recommended first-line treatment agents for ADHD, that were significantly reduced by using topiramate. New therapeutic options that would be easily used and with less side effects are needed in the treatment of TD. Topiramate treatment seems like an appropriate option raising hope for the future to be used as monotherapy or in adjuvant treatment for TD. Larger trials with longer follow up are required in this field.

EISSN 2475-0581